In last trading session, Veracyte Inc (NASDAQ:VCYT) saw 0.68 million shares changing hands with its beta currently measuring 2.00. Company’s recent per share price level of $31.51 trading at $1.08 or 3.55% at ring of the bell on the day assigns it a market valuation of $2.46B. That closing price of VCYT’s stock is at a discount of -50.17% from its 52-week high price of $47.32 and is indicating a premium of 40.94% from its 52-week low price of $18.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.11 million shares which gives us an average trading volume of 890.76K if we extend that period to 3-months.
Veracyte Inc (NASDAQ:VCYT) trade information
Upright in the green during last session for gaining 3.55%, in the last five days VCYT remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $31.51 price level, adding 2.57% to its value on the day. Veracyte Inc’s shares saw a change of -20.43% in year-to-date performance and have moved -1.59% in past 5-day. Veracyte Inc (NASDAQ:VCYT) showed a performance of -21.97% in past 30-days. Number of shares sold short was 3.39 million shares which calculate 3.63 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 44 to the stock, which implies a rise of 28.39% to its current value. Analysts have been projecting 44 as a low price target for the stock while placing it at a high target of 44. It follows that stock’s current price would drop -39.64% in reaching the projected high whereas dropping to the targeted low would mean a loss of -39.64% for stock’s current value.
Veracyte Inc (VCYT) estimates and forecasts
This year revenue growth is estimated to rise 9.43% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 110.54M for the same. And 10 analysts are in estimates of company making revenue of 121.56M in the next quarter. Company posted 96.84M and 114.43M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 62.37% while estimates for its earnings growth in next 5 years are of 53.44%.
Veracyte Inc (NASDAQ:VCYT)’s Major holders
Insiders are in possession of 0.85% of company’s total shares while institution are holding 104.61 percent of that, with stock having share float percentage of 105.51%. Investors also watch the number of corporate investors in a company very closely, which is 104.61% institutions for Veracyte Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at VCYT for having 7.79 million shares of worth $168.88 million. And as of 2024-06-30, it was holding 10.4241 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 7.5 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.0281 of outstanding shares, having a total worth of $162.46 million.
On the other hand, Vanguard Explorer Fund, Inc. and ARK ETF Tr-ARK Innovation ETF are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 2.8 shares of worth $88.23 million or 3.59% of the total outstanding shares. The later fund manager was in possession of 2.68 shares on Dec 31, 2024 , making its stake of worth around $84.59 million in the company or a holder of 3.44% of company’s stock.
